Stephen Saad
Pharmaceutical founder and executive
By South African Index Editorial Desk · Published · Updated · Last reviewed

Stephen Saad is a founding shareholder and group chief executive of Aspen Pharmacare. He and Gus Attridge were two of the four founding members of Aspen Healthcare, which began trading in 1997. [1][2]
Biography
Saad graduated from the University of Natal and qualified as a chartered accountant. Aspen’s company material records that he later co-founded Aspen Healthcare with Gus Attridge and two other founding members in 1997. [2][1]
Aspen began trading from a converted house in Greyville, Durban. The business listed on the JSE in 1998 through a reverse listing into Medhold Limited. [1][3]
In 1999 Aspen acquired South African Druggists for R2.4 billion, joining the young Aspen business to a much older South African pharmaceutical operation. Saad remained group chief executive as the company expanded internationally. [1]
Aspen’s FY2026 results identify Saad as Group Chief Executive. The release covers the year ended 30 June 2026. This role was checked on 15 October 2026, separately from the group’s founding history. [6]
Key contributions
Co-founded Aspen Healthcare in 1997 and continued as group chief executive. [1][2]
Led the company through its early JSE listing and major acquisition of South African Druggists. [3][1]
Life and career timeline
Frequently asked questions
Was Saad Aspen’s sole founder?
No. Aspen identifies Saad and Gus Attridge as two of four founding members. [4]
Does his chief executive title establish personal voting control?
No. A management title does not state an equity percentage or the voting rights attached to shares. [5]
Related people
Associated organisations
Related research
Sources
- Aspen Pharmacare, About Aspen. Original source. Accessed 2026-09-25. ↩
- Aspen Pharmacare, Stephen Saad named as Business Leader of the Year, 2012-11-16. Original source. Accessed 2026-09-25. ↩
- Aspen Pharmacare, Integrated Report 2016, 2016-06-30. Original source. Accessed 2026-09-25. ↩
- Aspen Pharmacare, About Aspen: history and current leadership. Original source. Accessed 2026-10-15. ↩
- Aspen Pharmacare, Integrated Report 2022: Attridge’s role transition, chairman’s review. Original source. Accessed 2026-10-15. ↩
- Aspen Pharmacare, Strong execution positions Aspen for sustainable growth: FY2026 results, 2026-09-02. Original source. Accessed 2026-10-15. ↩